Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-21-013279

Options or other derivatives

  • Chief Financial Officer bought 3,000 shares at $0.38 ($1,140)

From the SEC's structured data for this filing

Trades in this filing

Arrow Alexander K. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-27 Purchase : show line 1 in the form PTIXW Common Stock 5-year warrants strike price $4.98 +3,000 $0.38 $1,140 33,000 D
Loading xslF345X03/ownership.xml…